SEARCH

SEARCH BY CITATION

References

  • 1
    Lainson R & Shaw JJ. New World leishmaniasis – the neotropical Leishmania species. In CoxFEG, KreierJP & WakelinD (eds): Topley & Wilson’s Microbiology and Microbial Infections, 9th edn. London, Parasitology, Arnold, Vol. 5, 1998: 242266.
  • 2
    Lainson R & Shaw JJ. Leishmaniasis in the New World. In CollierL, BalowsA & SussmanM (eds): Topley & Wilson’s Microbiology and Microbial Infections, 10th edn. London, Parasitology, Arnold, Vol. 5, 2005: 313349.
  • 3
    Silveira FT, Lainson R, De Brito AC, et al. Leishmaniose tegumentar americana. In LeãoRNG (ed): Doenças Infecciosas e Parasitárias: Enfoque Amazônico, Belém, PA, CEJUP, 1997: 619630.
  • 4
    Silveira FT, Lainson R & Corbett CEP. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil. Mem Inst Oswaldo Cruz 2004; 99: 239251.
  • 5
    Silveira FT, Lainson R & Corbett CEP. Further observations on clinical, histopathological and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2005; 100: 525534.
  • 6
    Lainson R & Shaw JJ. Evolution, classification and geographical distribution. In PetersW & Killick-KendrickR (eds): The Leishmaniases in Biology and Medicine. London, Academic Press, Vol. 1, 1987: 1120.
  • 7
    Peters NC, Egen JG, Secundino N, et al. In vivo imaging reveals an essential role for neutrophil in leishmaniasis transmitted by sand flies. Science 2008; 321: 970974.
  • 8
    John B & Hunter CA. Neutrophil soldiers or Trojan horses? Science 2008; 321: 917918.
  • 9
    Laskay T, Van Zandbergem G & Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: Apoptosis as infection-promoting factor. Immunobiology 2008; 213: 183191.
  • 10
    Sacks DL & Perkins PV. Identification of an infective stage of Leishmania promastigotes. Science 1984; 223: 1417.
  • 11
    Sacks DL & Da Silva RP. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J Immunol 1987; 139: 3099.
  • 12
    Vannier-Santos MA, Martiny A & De Souza W. Cell biology of Leishmania spp.: invading and evading. Curr Pharm Des 2002; 8: 297318.
  • 13
    Petzl-Erler ML, Belich MP & Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol 1991; 32: 254260.
  • 14
    Lara ML, Layrisse Z, Scorsa JV, et al. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol 1991; 30: 129135.
  • 15
    Blackwell JM. Tumour necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today 1999; 15: 7376.
  • 16
    Castellucci L, Menezes E, Oliveira J, et al. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Inf Dis 2007; 194: 519527.
  • 17
    Campos MB, Gomes CMC, De Souza AAA, Lainson R, Corbett CEP & Silveira FT. In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis. Parasitol Res 2008; 108: 771776.
  • 18
    Silveira FT, Lainson R, Gomes CMC, Laurenti MD & Corbett CEP. Reviewing the role of the dendritic Langerhans cell in the immunopathogenesis of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2008; 102: 10751080.
  • 19
    Garg H, Trudel N & Trembley MJ. Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells. Trends Parasitol 2007; 23: 317324.
  • 20
    Soong L. Modulation of dendritic cell function by Leishmania parasites. J Immunol 2008; 180: 43554360.
  • 21
    Von Stebut E, Belkaid Y, Jacob T, Sacks DL & Udey MC. Uptake of Leishmania major amastigotes results in activation and IL-12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998; 188: 15471552.
  • 22
    Lemos MP, Esquivel F, Scott P & Laufer TM. MHC class II expression restricted to CD8α+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med 2004; 199: 725730.
  • 23
    Locksley RM, Heinzel FP, Holaday BJ, et al. Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res Immunol 1991; 142: 2832.
  • 24
    Sacks D & Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2: 845858.
  • 25
    Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 1998; 4: 557591.
  • 26
    Bogdan C, Donhauser N, Döring R, Röllinghoff M, Diefenbach A & Rittig MG. Fibroblasts as host cells in latent leishmaniosis. J Exp Med 2000; 191: 21212129.
  • 27
    Moll H, Flohé S & Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T-cell immune response. Eur J Immunol 1995; 25: 693699.
  • 28
    Girolomoni G, Caux C, Lebecque S, Dezutter-Dambuyant C & Ricciardi-Castagnoli P. Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cells. Trends Immunol 2002; 23: 68.
  • 29
    Ritter U, Meissner A, Scheidig C & Körner H. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 2004; 34: 15421550.
  • 30
    Kaplan DH, Jenison MC, Saeland S, Shlomchik WD & Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005; 23: 611620.
  • 31
    Ritter U & Osterloh A. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis. Med Microbiol Immunol 2007; 196: 5159.
  • 32
    Carvalho EM, Correia-Filho D, Baccelar O, Lessa H & Rocha H. Characterization of the immune response in subjects with self healing cutaneous leishmaniasis. Am J Trop Med Hyg 1995; 53: 273277.
  • 33
    Da-Cruz A, De Oliveira MP, De-Luca PM, Mendonça SC & Coutinho SG. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1996; 91: 225229.
  • 34
    Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70: 67346740.
  • 35
    Petersen EA, Neva FA, Oster CN & Diaz HB. Specific inhibition of lymphocyte proliferation response by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med 1982; 306: 387391.
  • 36
    Barral A, Costa JML, Bittencourt AL, Barral-Neto M & Carvalho EM. Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol 1995; 34: 474479.
  • 37
    Costa JML, Marsden PD, Llanos-Cuentas EA, et al. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J Trop Med Hyg 1986; 89: 319321.
  • 38
    Carvalho EM, Barral A, Costa JML, Bittencourt A & Marsden PD. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop 1994; 56: 315325.
  • 39
    Turetz ML, Machado PR, Ko AI, et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002; 186: 18291834.
  • 40
    Ribeiro-de-Jesus A, Almeida RP, Lessa H, Baccelar O & Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31: 143148.
  • 41
    Barral-Netto M, Brodskyn C, Carvalho EM & Barral A. Human-leishmaniasis@cytokines.bahia.br. Braz J Med Biol Res 1998; 31: 149155.
  • 42
    Campanelli AP, Roselino AM, Cavassani KA, et al. CD4+ CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of regulatory T cells. J Infect Dis 2006; 193: 13131322.
  • 43
    Cáceres-Dittmar G, Tapia FJ, Sanchez MA, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993; 91: 500505.
  • 44
    Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F & Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993; 91: 13901395.
  • 45
    Silveira FT, Lainson R, Shaw JJ, De Souza AAA, Ishikawa EA & Braga RR. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections. Trans R Soc Trop Med Hyg 1991; 85: 735738.
  • 46
    Silveira FT, Blackwell JM, Ishikawa EA, et al. T-cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunol 1998; 20: 1926.
  • 47
    Lemos de Souza V, Ascenção Souza J, Correia Silva TM, Sampaio Tavares Veras P & Rodrigues de Freitas LA. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect 2000; 2: 18071815.
  • 48
    Guimarães ET, Santos LA, Ribeiro dos Santos R, Teixeira MM, Dos Santos WL & Soares MB. Role of interluekin-4 and prostagladin E2 in Leishmania amazonensis infection of BALB/c mice. Mic Infect 2006; 8: 12191226.
  • 49
    Martinez-Arends A, Tapia FJ, Caceres-Dittmar G, Mosca W, Valecil L & Convit J. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop 1991; 49: 271280.
  • 50
    Faria DR, Gollob KJ, Barbosa J Jr, et al. Decrease in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005; 73: 78537859.
  • 51
    Bonfim G, Nascimento C, Costa JML, Carvalho EM, Barral-Neto M & Barral A. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol 1996; 84: 188194.
  • 52
    Peters N & Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006; 213: 159179.
  • 53
    Convit J, Pinardi ME & Rondon AJ. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972; 66: 603610.
  • 54
    Barral-Netto M, Cardoso SA & Barral A. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Acta Trop 1987; 44: 511.
  • 55
    Barral A, Pedral-Sampaio D, Grimaldi G Jr, et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Ame J Trop Med Hyg 1991; 44: 536546.
  • 56
    Viana da Costa A, Huerre M, Delacre M, Aurialt C, Correia Costa JM & Verwaerde C. IL-10 leads to a high parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol Int 2002; 51: 367379.
  • 57
    Villaseñor-Cardoso MI, Salaiza N, Delgado J, Gutierrez-Kobeh L, Perez-Torrez A & Becker I. Mast cells are activated by Leishmania mexicana LPG and regulate disease outcome depending on the genetic background of the host. Parasite Immunol 2008; 30: epub ahead of print.
  • 58
    Trujillo CM, Robledo SM, Franco JL, Velez ID, Erb KJ & Patinõ PJ. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis. Parasite Immunol 2002; 24: 455462.
  • 59
    Delgado G, Parra-López CA, Vargas LE, et al. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs). Parasite Immunol 2003; 25: 199209.
  • 60
    Calvopina M, Gomez EA, Sindermann H, Cooper PJ & Hashiguchi Y. Relapse of New World diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 2006; 75: 10741077.
  • 61
    Hsu AC & Scott P. Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol 2007; 179: 82008207.
  • 62
    Xavier MB, Silveira FT, Demachki S, Ferrreira MMR & Nascimento JL. American tegumentary leishmaniasis: A quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus. Acta Trop 2005; 95: 6773.
  • 63
    Carvalho LP, Pearce EJ & Scott P. Functional dichotomy of dendritic cells following interaction with Leishmania (V.) braziliensis: Infected cells produce high levels of TNF-α, whereas bystander dendritic cells are activated to promote T cell responses. J Immunol 2008; 181: 64736480.
  • 64
    Vargas-Inchaustegui DA, Xin L & Soong L. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses. J Immunol 2008; 180: 75377545.
  • 65
    Favali C, Tavares N, Clarêncio J, Barral A, Barral-Neto M & Brodskyn C. Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leuk Biol 2007; 82: 16.
  • 66
    Vasquez RE, Xin L & Sonng L. Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Infect Immun 2008; 76: 161169.